- Home
- CLPS vs CGTX Comparison
CLPS vs CGTX Comparison
Compare CLPS & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- CGTX
- Stock Information
- Founded
- CLPS 2005
- CGTX 2007
- Country
- CLPS Hong Kong
- CGTX United States
- Employees
- CLPS N/A
- CGTX N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- CGTX Health Care
- Exchange
- CLPS Nasdaq
- CGTX Nasdaq
- Market Cap
- CLPS 26.6M
- CGTX 23.1M
- IPO Year
- CLPS 2018
- CGTX 2021
- Fundamental
- Price
- CLPS $0.99
- CGTX $0.30
- Analyst Decision
- CLPS
- CGTX Strong Buy
- Analyst Count
- CLPS 0
- CGTX 5
- Target Price
- CLPS N/A
- CGTX $6.13
- AVG Volume (30 Days)
- CLPS 5.8K
- CGTX 803.7K
- Earning Date
- CLPS 03-05-2025
- CGTX 05-07-2025
- Dividend Yield
- CLPS 12.87%
- CGTX N/A
- EPS Growth
- CLPS N/A
- CGTX N/A
- EPS
- CLPS N/A
- CGTX N/A
- Revenue
- CLPS $153,816,045.00
- CGTX N/A
- Revenue This Year
- CLPS N/A
- CGTX N/A
- Revenue Next Year
- CLPS N/A
- CGTX N/A
- P/E Ratio
- CLPS N/A
- CGTX N/A
- Revenue Growth
- CLPS 5.81
- CGTX N/A
- 52 Week Low
- CLPS $0.68
- CGTX $0.31
- 52 Week High
- CLPS $1.70
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- CLPS 46.05
- CGTX 31.49
- Support Level
- CLPS $0.94
- CGTX $0.40
- Resistance Level
- CLPS $1.00
- CGTX $0.47
- Average True Range (ATR)
- CLPS 0.03
- CGTX 0.04
- MACD
- CLPS 0.00
- CGTX -0.01
- Stochastic Oscillator
- CLPS 56.92
- CGTX 11.16
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.